{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:37:57Z","timestamp":1791466677486,"version":"4.3.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ebiom.2025.105570","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T05:12:00Z","timestamp":1738905120000},"page":"105570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A phase 1b clinical trial to determine the safety, tolerability and immunogenicity of simian adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies in patients with active Crohn's disease"],"prefix":"10.1016","volume":"113","author":[{"given":"Jeremy","family":"Sanderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Aboagye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7582-9073","authenticated-orcid":false,"given":"Rebecca","family":"Makinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Rapi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8562-1921","authenticated-orcid":false,"given":"Samuel","family":"Provstgaard-Morys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Stockdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Alison Lawrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Lanigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishat","family":"Halim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel","family":"Douiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Greenlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayka","family":"Malek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"El Oulidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7376-7790","authenticated-orcid":false,"given":"Paul Ian","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Stallibrass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah C.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian V.S.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9827-9836","authenticated-orcid":false,"given":"Katie J.","family":"Ewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ebiom.2025.105570_bib1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nrg.2015.33","article-title":"Autoimmune diseases - connecting risk alleles with molecular traits of the immune system","volume":"17","author":"Gutierrez-Arcelus","year":"2016","journal-title":"Nat Rev Genet"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105570_bib2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.15252\/embr.201540241","article-title":"Attacking the system: next-generation auto-immune therapies target pathways rather than symptoms","volume":"16","author":"Hunter","year":"2015","journal-title":"EMBO Rep"},{"key":"10.1016\/j.ebiom.2025.105570_bib3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3389\/fimmu.2015.00096","article-title":"Mycobacterium avium ss. paratuberculosis zoonosis \u2013 the hundred year war \u2013 beyond Crohn\u2019s disease","volume":"6","author":"Sechi","year":"2015","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105570_bib4","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3390\/v15010204","article-title":"The adenovirus vector platform: novel insights into rational vector design and lessons learned from the COVID-19 vaccine","volume":"15","author":"Sallard","year":"2023","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105570_bib5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/vaccines7020040","article-title":"Safety and immunogenicity of a novel recombinant simian adenovirus ChAdOx2 as a vectored vaccine","volume":"7","author":"Folegatti","year":"2019","journal-title":"Vaccines"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105570_bib6","doi-asserted-by":"crossref","first-page":"e663","DOI":"10.1016\/S2666-5247(22)00126-4","article-title":"Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial","volume":"3","author":"Jenkin","year":"2022","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.ebiom.2025.105570_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1757-4749-1-25","article-title":"A\u00a0rhodanine agent active against non-replicating intracellular Mycobacterium avium subspecies paratuberculosis","volume":"1","author":"Bull","year":"2009","journal-title":"Gut Pathog"},{"issue":"3\u20134","key":"10.1016\/j.ebiom.2025.105570_bib8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0378-1135(00)00330-8","article-title":"Further studies on the GS element. A novel mycobacterial insertion sequence (IS1612), inserted into an acetylase gene (mpa) in Mycobacterium avium subsp. silvaticum but not in Mycobacterium avium subsp. paratuberculosis","volume":"77","author":"Bull","year":"2000","journal-title":"Vet Microbiol"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105570_bib9","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1128\/IAI.68.2.801-808.2000","article-title":"Alkyl hydroperoxide reductases C and D are major antigens constitutively expressed by Mycobacterium avium subsp. paratuberculosis","volume":"68","author":"Olsen","year":"2000","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105570_bib10","first-page":"57","article-title":"Use of bioinformatics to predict a function for the GS element in Mycobacterium avium subspecies paratuberculosis","volume":"5","author":"Sheridan","year":"2003","journal-title":"J\u00a0Mol Microbiol Biotechnol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105570_bib11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13567-014-0112-9","article-title":"Immunity, safety and protection of an Adenovirus 5 prime - Modified Vaccinia virus\u00a0Ankara boost subunit vaccine against Mycobacterium avium subspecies paratuberculosis infection in calves","volume":"45","author":"Bull","year":"2014","journal-title":"Vet Res"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105570_bib12","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3390\/vaccines9030262","article-title":"Safety and immunogenicity of adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies","volume":"9","author":"Folegatti","year":"2021","journal-title":"Vaccines"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105570_bib13","first-page":"283","article-title":"An attenuated strain of vaccinia virus (MVA). Successful intramuscular immunization against vaccinia and variola (author\u2019s translation)","volume":"230","author":"Hochstein-Mintzel","year":"1975","journal-title":"Zentralblatt Bakteriol Parasitenkd Infekt Hyg Erste Abt Orig Reihe Med Mikrobiol Parasitol"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105570_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208328","article-title":"First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children","volume":"13","author":"Tiono","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105570_bib15","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn\u2019s disease activity index. National cooperative Crohn\u2019s disease study","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ebiom.2025.105570_bib16","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1111\/j.1572-0241.2008.02176.x","article-title":"Defining the optimal response criteria for the Crohn\u2019s Disease Activity Index for induction studies in patients with mildly to moderately active Crohn\u2019s disease","volume":"103","author":"Thia","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105570_bib17","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3390\/biomedicines11020544","article-title":"Defining the failure of medical therapy for inflammatory bowel disease in the era of advanced therapies: a systematic review","volume":"11","author":"State","year":"2023","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105570_bib18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1053\/j.gastro.2014.08.003","article-title":"Converging goals of treatment of inflammatory bowel disease from clinical trials and practice","volume":"148","author":"Levesque","year":"2015","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105570_bib19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/gutjnl-2013-304984","article-title":"Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn\u2019s disease in the SONIC trial","volume":"63","author":"Peyrin-Biroulet","year":"2014","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105570_bib20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0016-5107(04)01878-4","article-title":"Development and validation of a new, simplified endoscopic activity score for Crohn\u2019s disease: the SES-CD","volume":"60","author":"Daperno","year":"2004","journal-title":"Gastrointest Endosc"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105570_bib21","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1053\/j.gastro.2013.08.010","article-title":"Validation of endoscopic activity scores in patients with Crohn\u2019s disease based on a post hoc analysis of data from SONIC","volume":"145","author":"Ferrante","year":"2013","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105570_bib22","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/gutjnl-2015-309903","article-title":"IOIBD technical review on endoscopic indices for Crohn\u2019s disease clinical trials","volume":"65","author":"Vuitton","year":"2016","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105570_bib23","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1002\/ibd.21300","article-title":"Endoscopic evaluation of Crohn\u2019s disease activity: comparison of the CDEIS and the SES-CD","volume":"16","author":"Sipponen","year":"2010","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105570_bib24","doi-asserted-by":"crossref","first-page":"e569","DOI":"10.1016\/j.crohns.2013.04.005","article-title":"Relationship between levels of angiogenic and lymphangiogenic factors and the endoscopic, histological and clinical activity, and acute-phase reactants in patients with inflammatory bowel disease","volume":"7","author":"Algaba","year":"2013","journal-title":"J\u00a0Crohns Colitis"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105570_bib25","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1365-2036.2008.03835.x","article-title":"Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn\u2019s disease and histological findings","volume":"28","author":"Sipponen","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105570_bib26","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.crohns.2014.02.014","article-title":"Serum ficolin-2 correlates worse than fecal calprotectin and CRP with endoscopic Crohn\u2019s disease activity","volume":"8","author":"Schaffer","year":"2014","journal-title":"J\u00a0Crohns Colitis"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105570_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048322","article-title":"A\u00a0T cell-inducing influenza vaccine for the elderly: safety and immunogenicity of MVA-NP+M1 in adults aged over 50 years","volume":"7","author":"Antrobus","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105570_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciq015","article-title":"Potent CD8+ T cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA\u2212NP+M1","volume":"52","author":"Berthoud","year":"2011","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105570_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167951","article-title":"Safety, immunogenicity and efficacy of prime-boost vaccination with ChAd63 and MVA encoding ME-TRAP against plasmodium falciparum infection in adults in Senegal","volume":"11","author":"Mensah","year":"2016","journal-title":"PLoS One"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425000143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425000143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T16:18:45Z","timestamp":1762618725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425000143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":29,"alternative-id":["S2352396425000143"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105570","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A phase 1b clinical trial to determine the safety, tolerability and immunogenicity of simian adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies in patients with active Crohn's disease","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105570","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105570"}}